$13.740
+0.224 (+1.63%)收盤時
TRXB 同業比較
In the context of the broader market, TRXB competes directly with industry leaders such as RZLT and AVTX. With a market capitalization of $377.16M, it holds a significant position in the sector. When comparing efficiency, TRXB's gross margin of N/A stands against RZLT's N/A and AVTX's N/A. Such benchmarking helps identify whether TRex Bio, Inc. is trading at a premium or discount relative to its financial performance.
TRex Bio, Inc. Common stock 財務表現
The financial metrics show a P/E ratio of 0 and a forward P/E of 0, suggesting no earnings expectations. The EV to EBITDA is negative at -8.61, indicating potential issues with profitability.
Financials
No data
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。